The bioscience industry veteran warns that one of San Antonio's more promising companies may need a deeper bench to reach its goal.
News
- Former SA biotech CEO talks abrupt exit after key wins
- Southern Missouri Bancorp (SMBC) to pay $0.15 on Nov 29, 2019; Anixa Biosciences (ANIX ...
The SI to Anixa Biosciences Inc's float is 6.86%. ... their article: “Anixa Biosciences Announces Collaboration with Urology San Antonio on Cchekâ„¢ ...
- Four San Antonio research institutions join together for partnership in precision therapeutics
The new San Antonio Partnership for Precision Therapeutics (SA PPT) is being established by UT Health San Antonio, Texas Biomedical Research ...
- Neurocrine: 3Q Earnings Snapshot
SAN DIEGO (AP) _ Neurocrine Biosciences Inc. (NBIX) on Monday reported third-quarter earnings of $53.8 million. The San Diego-based company ...
- Agenus: 3Q Earnings Snapshot
The biotechnology company posted revenue of $19.9 million in the period. The company's shares closed at $2.85. A year ago, they were trading at ...